October 03, 2013
The U.S. Judicial Panel on Multidistrict Litigation on Wednesday selected Rhode Island for the centralization of six nationwide class actions accusing pharmaceutical company Warner Chilcott PLC of illegally muscling generic competitors for its oral contraceptive Loestrin out of the market.